Sandborn, W., Yeager, B., Gasink, C., Hoops, T., Gao, L., Wang, Y., . . . Hanauer, S. (2018). A108 USTEKINUMAB IV INDUCTION RESULTS IN CROHN’S DISEASE SYMPTOM IMPROVEMENT WITHIN THE FIRST WEEK IN ANTI-TNF REFRACTORY PATIENTS. J Can Assoc Gastroenterol.
Chicago-stil citatSandborn, W., B. Yeager, C. Gasink, T. Hoops, L. Gao, Y. Wang, D. Jacobstein, S D. Lee, och S. Hanauer. "A108 USTEKINUMAB IV INDUCTION RESULTS IN CROHN’S DISEASE SYMPTOM IMPROVEMENT WITHIN THE FIRST WEEK IN ANTI-TNF REFRACTORY PATIENTS." J Can Assoc Gastroenterol 2018.
MLA-referensSandborn, W., et al. "A108 USTEKINUMAB IV INDUCTION RESULTS IN CROHN’S DISEASE SYMPTOM IMPROVEMENT WITHIN THE FIRST WEEK IN ANTI-TNF REFRACTORY PATIENTS." J Can Assoc Gastroenterol 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.